TORRENT PHARMACEUTICALS
|
The Current P/E Ratio of TORRENT PHARMACEUTICALS is 84.30.
| Share Price | ₹4,778.0 | Oct 06,2026 |
| Market Cap | ₹181,755.1 Cr | |
| Earnings-TTM | ₹2,156.0 Cr | TTM-Consolidated Results |
| Price/Earnings | 84.30x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of TORRENT PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹181,755.1 Cr] as on Oct 06,2026
(/) Earnings [ ₹2,156.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 84.30x ]
Thus, for TORRENT PHARMACEUTICALS , the investors are currently willing to pay 84.30 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of TORRENT PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of TORRENT PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of TORRENT PHARMACEUTICALS
PE Ratio Performance Analysis for TORRENT PHARMACEUTICALS
- TORRENT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 49.74x.
- TORRENT PHARMACEUTICALS 's operated at median p/e ratio of 53.15x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, TORRENT PHARMACEUTICALS 's p/e ratio peaked in Mar2026 at 66.03x.
- TORRENT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2022 of 30.45x.
How does TORRENT PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| TORRENT PHARMACEUTICALS | 2,156.00 | 84.30 | 181,755.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 35.50 | 432,120.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 86.63 | 253,390.0 |
| CIPLA LTD | 3,364.84 | 32.24 | 108,497.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 31.84 | 100,925.0 |
| MANKIND PHARMA LTD | 2,055.11 | 49.95 | 102,650.0 |
| LUPIN LTD | 5,551.01 | 16.76 | 93,058.5 |
| ZYDUS LIFESCIENCES LTD | 4,492.20 | 25.76 | 115,710.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 26.19 | 97,238.9 |
| LAURUS LABS LTD | 1,090.76 | 101.75 | 110,980.0 |
| BIOCON LTD | 416.40 | 144.26 | 60,070.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs TORRENT PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 16.76x |
| Max industry PE | 144.26x |
| Median industry PE | 35.50x |
| Average industry PE | 57.74x |
You may also like the below Video Courses